Identification of a p53 response element in the promoter region of the hMSH2 gene required for expression in A2780 ovarian cancer cells.

Type-specific cell line models for type-specific ovarian cancer research. PLoS One (2013) 1.73

The transcription factor p53: not a repressor, solely an activator. Cell Cycle (2014) 1.23

Transcriptional regulation of human DNA repair genes following genotoxic stress: trigger mechanisms, inducible responses and genotoxic adaptation. Nucleic Acids Res (2013) 1.03

The ubiquitin-proteasome system in cancer, a major player in DNA repair. Part 2: transcriptional regulation. J Cell Mol Med (2009) 0.86

hMSH2 expression is driven by AP1-dependent regulation through phorbol-ester exposure. Nucleic Acids Res (2003) 0.84

Gene expression patterns in heterozygous Plk4 murine embryonic fibroblasts. BMC Genomics (2009) 0.82

Census and evaluation of p53 target genes. Oncogene (2017) 0.77

A randomized trial of cisplatin, vinblastine, and bleomycin versus vinblastine, cisplatin, and etoposide in the treatment of advanced germ cell tumors of the testis: a Southwest Oncology Group study. J Clin Oncol (1991) 1.38

Binding of 3,5,3'-triiodothyronine (T3) and its analogs to the in vitro translational products of c-erbA protooncogenes: differences in the affinity of the alpha- and beta-forms for the acetic acid analog and failure of the human testis and kidney alpha-2 products to bind T3. Mol Endocrinol (1990) 1.14

Plasticity in the synthesis and storage of substance P and calcitonin gene-related peptide in primary afferent neurons during peripheral inflammation. Neuroscience (1995) 1.06

Streptococcus mitis sepsis in bone marrow transplant patients receiving oral antimicrobial prophylaxis. Am J Med (1990) 1.03

Quantitation of rat tissue thyroid hormone binding receptor isoforms by immunoprecipitation of nuclear triiodothyronine binding capacity. J Biol Chem (1992) 0.98

Thyroid hormone action 1994: the plot thickens. Eur J Endocrinol (1994) 0.95

Identification of thyroid hormone response elements in rodent Pcp-2, a developmentally regulated gene of cerebellar Purkinje cells. J Biol Chem (1994) 0.91

Effect of pioglitazone on survival and renal function in a mouse model of polycystic kidney disease. Am J Nephrol (2009) 0.90

Immunocytochemical delineation of thyroid hormone receptor beta 2-like immunoreactivity in the rat central nervous system. Endocrinology (1993) 0.89

Natural killer cells in in utero diethylstilbesterol-exposed patients. Gynecol Oncol (1983) 0.83

CR with lenalidomide in del(5)(q13q33) AML relapsing after allogeneic hematopoietic SCT. Bone Marrow Transplant (2009) 0.82

Purkinje cell protein-2 cis-elements mediate repression of T3-dependent transcriptional activation. Mol Cell Endocrinol (1997) 0.81

Disseminated histoplasmosis in allogeneic bone marrow transplant: a diagnosis not to be missed. Transpl Infect Dis (2014) 0.80

Immunofluorescent localization of thyroid hormone receptor isoforms in glial cells of rat brain. Endocrinology (1994) 0.80

Ontogeny of hepatic nuclear triiodothyronine receptor isoforms in the rat. Endocrinology (1992) 0.79

Idiopathic interstitial pulmonary fibrosis. An immune complex disease? Am Rev Respir Dis (1973) 0.79

Time course of hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and messenger ribonucleic acid, biliary lipid secretion, and hepatic cholesterol content in methimazole-treated hypothyroid and hypophysectomized rats after triiodothyronine administration: possible linkage of cholesterol synthesis to biliary secretion. Endocrinology (1989) 0.79

Thyroid hormone receptor isoform content in cultured type 1 and type 2 astrocytes. Endocrinology (1996) 0.77

A Purkinje cell protein-2 intronic thyroid hormone response element binds developmentally regulated thyroid hormone receptor-nuclear protein complexes. J Mol Neurosci (1996) 0.77

Dopamine autoreceptor regulation of the kinetic state of striatal tyrosine hydroxylase. Mol Pharmacol (1986) 0.76

Facing the free riders. Ohio State Med J (1979) 0.75

Reflections on Ohio's malpractice climate. Ohio State Med J (1984) 0.75

Taking charge. Interview by Carol Wright Mullinax. Ohio State Med J (1982) 0.75

Prolonged fasting reduces rat hepatic beta 1 thyroid hormone receptor protein without changing the level of its messenger ribonucleic acid. Endocrinology (1991) 0.75

Breaking new ground. Questions and answers about OSMA's new Group Professional Liability Plan. Ohio State Med J (1982) 0.75

Disposal of sharps: implications and control. J Intraven Nurs (1990) 0.75

Molecular mechanisms of thyroid hormone action. A physiologic perspective. Clin Lab Med (1993) 0.75

Effect of thyroid hormone status on the expression of the mRNAs of components of the lipolytic regulatory cascade in brown adipose tissue. Int J Biochem (1992) 0.75